Search Results for "Neupro"

10:25 EDT 10th October 2015 | BioPortfolio

Matching Channels


Matching News

UCB's Neupro meets in Chinese Phase III PD trial

UCB Group (Euronext:UCB) reported detailed data from a Phase III trial of Neupro rotigotine in Chinese patients with early stage Parkinson's disease (PD). The company announced top-line results in Feb...

UCB Patch Product for Parkinson's Passes China Phase III Test

UCB, the Belgian biopharma, reported positive results from a China Phase III trial of its transdermal patch product, NEUPRO®, a treatment for early stage Parkinson's disease. NEUPRO (rotigotine) i...

BRIEF-UCB announces data from Neupro phase 3 study

* Announces first presentation of data from Neupro (rotigotine transdermal patch) phase 3 study in China at international congress

Neupro rotigotine: Phase III data

Important UCB presence at the 2015 American Academy of Neurology Meeting

BRUSSELS, April 20, 2015 /PRNewswire/ -- UCB, a global biopharmaceutical company focusing on neurology and immunology treatment and research, is sponsoring a total of 24 data presentations at the...

Global Neurodegenerative Diseases Market 2015-2019

Recently added to the BioPortfolio report store, Global Neurodegenerative Diseases Market 2015-2019 is a new report from Technavio published on 2015-05-05. This 168-page report is available in pdf fr...

Matching PubMed Articles


Search Whole site using Google


Advertisement Advertisement